Literature DB >> 21709606

Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.

Fabrice Porcheray1, David B Miklos, Blair H Floyd, Stefanie Sarantopoulos, Roberto Bellucci, Robert J Soiffer, Joseph H Antin, Edwin P Alyea, Jerome Ritz, Emmanuel Zorn.   

Abstract

BACKGROUND: Antibody responses to HY antigens in male recipients are frequent after transplantation of stem cells from female donors (Miklos et al., Blood 2005; 105: 2973; Miklos et al., Blood 2004; 103: 353). However, evidence that this B-cell immunity is accompanied by T-cell responses to the cognate antigens is scarce. Here, we examined T- and B-cell responses to DBY antigen in a male patient who received hematopoietic stem cells from a human leukocyte antigen-identical female sibling.
MATERIALS AND METHODS: We used 93 overlapping peptides representing the entire DBY protein to detect and characterize T-cell and antibody responses to DBY by enzyme-linked immunosorbent spot (ELISPOT) and enzyme-linked immunosorbent assay.
RESULTS: High frequency CD4+ T cells specific for a unique DBY peptide were detected in the patient blood. We isolated the corresponding T-cell clone and characterized the recognized epitope as an 18-mer peptide restricted by human leukocyte antigen-DRB1*0101. Upon stimulation, this clone produced cytokines with no evidence of Th1 or Th2 polarization. Remarkably, this clone also recognized the DBX homologue peptide and responded to female donor dendritic cells stimulated with poly I/C or lipopolysaccharide, indicating that the peptide was endogenously processed in these cells. High titer DBY-specific antibodies were also found in the patient serum which, in contrast to the T-cell response, did not cross-react with DBX.
CONCLUSION: We show here the development of a coordinated B and T-cell response to DBY in a recipient of sex mismatched allogeneic hematopoietic stem-cell transplantation. Our findings support a role for CD4+ T cells in the development of humoral immunity to minor histocompatibility antigens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21709606      PMCID: PMC3263512          DOI: 10.1097/TP.0b013e3182244cc3

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

1.  Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique.

Authors:  R A Pierce; E D Field; J M den Haan; J A Caldwell; F M White; J A Marto; W Wang; L M Frost; E Blokland; C Reinhardus; J Shabanowitz; D F Hunt; E Goulmy; V H Engelhard
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

2.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection.

Authors:  M H Vogt; R A de Paus; P J Voogt; R Willemze; J H Falkenburg
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

4.  Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Edwin P Alyea; Haesook T Kim; Vincent Ho; Corey Cutler; Daniel J DeAngelo; Richard Stone; Jerome Ritz; Joseph H Antin; Robert J Soiffer
Journal:  Biol Blood Marrow Transplant       Date:  2006-10       Impact factor: 5.742

5.  A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

Authors:  Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

Review 6.  Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis.

Authors:  Mohamed A Kharfan-Dabaja; Asmita R Mhaskar; Benjamin Djulbegovic; Corey Cutler; Mohamad Mohty; Ambuj Kumar
Journal:  Biol Blood Marrow Transplant       Date:  2009-06-10       Impact factor: 5.742

7.  The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

Authors:  Mario H J Vogt; Joost W van den Muijsenberg; Els Goulmy; Eric Spierings; Petra Kluck; Michel G Kester; Ronald A van Soest; Jan W Drijfhout; Roel Willemze; J H Frederik Falkenburg
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

8.  Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Authors:  David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

9.  B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans.

Authors:  F Porcheray; W Wong; S L Saidman; J De Vito; T C Girouard; M Chittenden; J Shaffer; N Tolkoff-Rubin; B R Dey; T R Spitzer; R B Colvin; A B Cosimi; T Kawai; D H Sachs; M Sykes; E Zorn
Journal:  Am J Transplant       Date:  2009-07-16       Impact factor: 8.086

10.  Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation.

Authors:  Eric Spierings; Corine J Vermeulen; Mario H Vogt; Lucie E E Doerner; J H Frederik Falkenburg; Tuna Mutis; Els Goulmy
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

View more
  12 in total

Review 1.  Aberrant B-cell homeostasis in chronic GVHD.

Authors:  Stefanie Sarantopoulos; Jerome Ritz
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

Review 2.  B cells in chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Bruce R Blazar; Corey Cutler; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-12       Impact factor: 5.742

3.  Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

Authors:  Kathy S Wang; Haesook T Kim; Sarah Nikiforow; Alexander T Heubeck; Vincent T Ho; John Koreth; Edwin P Alyea; Philippe Armand; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Corey S Cutler; Jerome Ritz
Journal:  Blood       Date:  2017-11-14       Impact factor: 22.113

4.  Allogeneic T cells: maestro in the co-ordination of the immune response after hematopoietic stem cell transplantation.

Authors:  Aurore Saudemont; J Alejandro Madrigal
Journal:  Haematologica       Date:  2014-02       Impact factor: 9.941

Review 5.  B-cell targeting in chronic graft-versus-host disease.

Authors:  Robert Zeiser; Stefanie Sarantopoulos; Bruce R Blazar
Journal:  Blood       Date:  2018-02-01       Impact factor: 22.113

Review 6.  B cells in chronic graft-versus-host disease.

Authors:  William McManigle; Ayman Youssef; Stefanie Sarantopoulos
Journal:  Hum Immunol       Date:  2019-03-05       Impact factor: 2.850

7.  Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.

Authors:  Robert S Nickel; Jeanne E Hendrickson; Marianne M Yee; Robert A Bray; Howard M Gebel; Leslie S Kean; David B Miklos; John T Horan
Journal:  Br J Haematol       Date:  2015-04-19       Impact factor: 6.998

Review 8.  Clinical impact of H-Y alloimmunity.

Authors:  Rakesh Popli; Bita Sahaf; Hideki Nakasone; Joyce Yeuk Yu Lee; David B Miklos
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

9.  Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation.

Authors:  Anita N Kremer; Judith C van der Griendt; Edith D van der Meijden; M Willy Honders; Burcu Ayoglu; Jochen M Schwenk; Peter Nilsson; J H Frederik Falkenburg; Marieke Griffioen
Journal:  Haematologica       Date:  2013-10-04       Impact factor: 9.941

10.  Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.

Authors:  Edouard Forcade; Haesook T Kim; Corey Cutler; Kathy Wang; Ana C Alho; Sarah Nikiforow; Vincent T Ho; John Koreth; Philippe Armand; Edwin P Alyea; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2016-03-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.